Gabapentina e pregabalina em transtorno bipolar, estados de ansiedade e insônia: revisão sistemática, metanálise e racional.
17 Mai, 2022 | 11:47h
Comentário no Twitter
SR: there is moderate evidence of the efficacy of gabapentinoids in anxiety states (SMD ranging between -2.25 and -0.25), but minimal evidence in bipolar disorder and insomnia and they should be used for these disorders only with strong justification https://t.co/zrxduX2q6l pic.twitter.com/6mKYwHKKbo
— PfOL (@psychopharmacol) May 12, 2022
Sob licença de http://creativecommons.org/licenses/by/4.0/


